• Info
  • Insider Ownership

Insider Trading & Ownership of Jeffrey W. Albers

Location
Cambridge, MA
Summary
The estimated net worth of Jeffrey W. Albers is at least $10.3M dollars as of 14 Oct 2025. Jeffrey W. Albers is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $9.33M. Jeffrey W. Albers is the Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $1.01M.
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Jeffrey W. Albers files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Jeffrey W. Albers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp Director $9.33M -$3.85M -29.2% 17 Jul 2025
SYRE Spyre Therapeutics, Inc. Director $1.01M 29 May 2025
KYMR Kymera Therapeutics, Inc. Director $0 -$607K -100% 13 Oct 2025
DNTH Dianthus Therapeutics, Inc. /DE/ Director 28 Jun 2022

Insider Transactions Reported by Jeffrey W. Albers:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.